MetLife

MET

Market cap $54.3B

A value stock is generally one that trades at a price lower than its fundamental value or what its performance suggests it should be worth.

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it will hold its third quarter 2025 earnings conference call and audio webcast on Thursday, November 6, 2025, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its third quarter 2025 earnings news release and Third Quarter 2025 Financial Supplement on Wednesday, November 5, 2025, after the market closes. The news release and Third Quarter 2025 Financial Supplement will also be available on the MetLife Invest.

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a fourth quarter 2025 common stock dividend of $0.5675 per share. The dividend will be payable on Dec. 9, 2025, to shareholders of record as of Nov. 4, 2025. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to hel.

NEW YORK--(BUSINESS WIRE)-- #PRT--Amid ongoing market conditions and economic uncertainty, U.S. plan sponsors are moving decisively to reduce pension risk. According to the newly released MetLife's 2025 Pension Risk Transfer (PRT) Poll, a record 94% of defined benefit (DB) pension plan sponsors with de-risking goals intend to fully divest their pension liabilities with 80% planning to do so within five years. The company's latest research shows market volatility is driving plan sponsors to de-risk, wh.

MET teams up with Global Citizen in a three-year initiative to expand education access, strengthen equity and create global social impact.

MetLife remains financially robust, with preferred dividends well covered by net income and ongoing share repurchases supporting shareholder value. MET.PR.E fixed-rate preferred shares offer a 5.7% stripped yield, trade below par, and present an attractive spread over 5-year Treasuries. Call risk for MET.PR.E rises as rates fall, but the yield and price below $25 make it appealing; Series F offers lower call risk for cautious investors.

NEW YORK--(BUSINESS WIRE)--Today at the 2025 Global Citizen Festival, MetLife, a leading financial services company providing insurance and employee benefits, proudly announced becoming a major partner with Global Citizen, the world's largest movement to end extreme poverty, with a new three-year partnership. This new partnership leverages MetLife's strengths and long history of enabling economic security, access to resources and resilience to thrive to further Global Citizen's mission and addr.

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.00002 percent of MetLife's shares of common stock outstanding as of August 31, 2025. Potemkin's offer price of $53.00 per share is approximately 34.42 percent lower than the $80.82 closing price of MetLife commo.

MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management experts for patients starting in 2026.

NEW YORK--(BUSINESS WIRE)--MetLife has introduced a new Cancer Support benefit to help employees with personalized advice and attention from diagnosis to treatment and through recovery. Through a strategic relationship with Private Health Management, a leader in complex care navigation, MetLife will expand its Critical Illness Insurance offering to provide a more robust cancer benefit, including access to top oncology specialists, tech-enabled and expert-led coordination, and patient counseling.